Microlin Bio sets IPO range

Microlin Bio Inc. (New York, N.Y.) amended its IPO on NASDAQ and now plans to sell 2.7 million shares at $10-$12. At the $11 midpoint, the company would raise $30 million and be valued at $75.1 million. Brean Capital and Summer Street Research Partners are underwriters. In January, Microlin Bio filed to raise $25 million through the sale of a to-be-determined number of shares at $6-$8. ...